This content is from: Patents
Associations call for Section 101 overhaul in comments to USPTO
PhRMA, ABA and AIPLA have submitted comments to the USPTO, and IPO has passed a resolution, all urging legislative changes to Section 101
To access our in-house intelligence please request a trial here.
Read this article – and more – for a 30 day period.
REQUEST ACCESSAre you already an Managing IP subscriber? Login here